CH Polman

4.4k citations

50 papers · 3.0k indexed · 2 hit papers · h-index 24

Pathology and Forensic Medicine top 0.2%
- Multiple Sclerosis Research Studies 35
- Systemic Sclerosis and Related Diseases 5
Neurology top 1%
- Peripheral Neuropathies and Disorders 13
Rheumatology top 1%
- Systemic Lupus Erythematosus Research 8
- Rheumatoid Arthritis Research and Therapies 4
Developmental Neuroscience top 5%
Neurology top 5%
- Peripheral Neuropathies and Disorders 13
Oncology
- Polyomavirus and related diseases 4
Molecular Biology
- RNA regulation and disease 4
Pharmacology
- Cannabis and Cannabinoid Research 3

Co-authors: Frederik Barkhof J.H.T.M. van Waesberghe Rivka Ravid Philip Scheltens Alan J. Thompson M.A.A. van Walderveen Wouter Kamphorst J. Valk
Cited by: Pathology and Forensic Medicine Neurology Rheumatology
Journals: Multiple Sclerosis Journal (12 papers)Neurology (6 papers)Journal of Neurology (5 papers)
Partner nations: Netherlands United Kingdom Italy

In The Last Decade

CH Polman

49 papers receiving 2.9k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by CH Polman

Since Specialization

Citations

This map shows the geographic impact of CH Polman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CH Polman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CH Polman more than expected).

Fields of papers citing papers by CH Polman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CH Polman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CH Polman. The network helps show where CH Polman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside CH Polman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with CH Polman Line = papers co-authored together CH Polman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Serum 25-hydroxyvitamin D concentrations among patients in BENEFIT predicts conversion to multiple sclerosis, MRI lesions, and brain volume loss UCL Discovery (University College London) ·Alberto Ascherio,Kassandra L. Munger,Chantal Simon,Ludwig Kappos,CH Polman,HP Hartung,D. H. Miller,Xavier Montalbán,Gilles Edan,Frederik Barkhof,Richard White,Rupert Sandbrink,Christoph Pohl	2012	2
2	Gene-expression signatures: biomarkers toward diagnosing multiple sclerosis Genes and Immunity ·John T. Tossberg,Philip S. Crooke,Melodie A. Henderson,Sriram Sampath,Andersen Na,Shilpa Chitnis,CH Polman,Saskia Vosslamber,C L Verweij,Nancy J. Olsen,Thomas M. Aune	2011	18
3	T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis Journal of Neurology Neurosurgery & Psychiatry ·Benedetta Bodini,Marco Battaglini,Nicola De Stefano,Zhaleh Khaleeli,Frederik Barkhof,Declan Chard,Massimo Filippi,Xavier Montalbán,CH Polman,Marco Rovaris,Àlex Rovira,Rebecca S. Samson,D. H. Miller,Alan J. Thompson,Olga Ciccarelli	2010	44
4	A three-year, multi-parametric MRI study in patients at presentation with CIS Journal of Neurology ·Maria A. Rocca,Federica Agosta,Maria Pia Sormani,Kryshani Fernando,Mar Tintoré,T. Korteweg,Paola Tortorella,David H. Miller,Alan J. Thompson,A. Rovira,Xavier Montalbán,CH Polman,Frederik Barkhof,Massimo Filippi	2008	52
5	Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics? Multiple Sclerosis Journal ·T. Korteweg,Marco Rovaris,Zbigniew Stanuch,Massimo Filippi,Giancarlo Comi,Bernard M.J. Uitdehaag,Kudakwashe Chitambire,CH Polman,Frederik Barkhof,Hugo Vrenken	2008	14
6	Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b Journal of Neurology ·CH Polman,Ludwig Kappos,Mark S. Freedman,Gilles Edan,H-P Hartung,David H. Miller,Xavier Montalbán,Frederik Barkhof,Krzysztof Selmaj,Bernard M.J. Uitdehaag,S. Dahms,Lars Bauer,Christoph Pohl,Rupert Sandbrink,(unknown)	2007	55
7	BG00012, a novel oral fumarate, is effective in patients with relapsing-remitting multiple sclerosis UCL Discovery (University College London) ·Ludwig Kappos,D. H. Miller,David MacManus,Ralf Gold,Eva Havrdová,Ian Czencz,CH Polman,Klaus Schmierer,A Yazdi Zadeh,Min Yang,Mefkûre Eraksoy,Eva Meluzínová,Ivan Rektor,Mdcccxxix Carolo	2006	11
8	Pain in Parkinson's disease and multiple sclerosis: Its relation to the medial and lateral pain systems Neuroscience & Biobehavioral Reviews ·Erik Scherder,Erik Ch. Wolters,CH Polman,J SERGEANT,Dick F. Swaab	2005	59
9	The distribution of magnetic resonance imaging response to interferonβ–1b in multiple sclerosis Journal of Neurology ·Maria Pia Sormani,Paolo Bruzzi,K. Beckmann,Ludwig Kappos,G. Poli,CH Polman,Carlo Pozzilli,Alan J. Thompson,Klaus Wagner,Massimo Filippi	2005	19
10	A longitudinal study of cognition in primary progressive multiple sclerosis Brain ·稠夫山口,Valerie L. Stevenson,Alan J. Thompson,Gordon Ingle,David H. Miller,Cecilia Borrás,Bruno Brochet,Vincent Dousset,Monica Falautano,Massimo Filippi,Nynke F. Kalkers,Xavier Montalbán,CH Polman,Dawn Langdon	2005	77
11	Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of Interferon beta-1b in patients with Secondary Progressive Multiple Sclerosis Journal of Neurology ·Peter Rieckmann,Niels Kruse,Lex Nagelkerken,K. Beckmann,D. H. Miller,CH Polman,Frank Dahlke,K. V. Toyka,Hans‐Peter Hartung,S Stürzebecher	2005	11
12	CTLA-4 and CD28 gene polymorphisms in susceptibility, clinical course and progression of multiple sclerosis Journal of Neuroimmunology ·(unknown),C. Augstein,Y. LABORDA,E. D'Emilio,Frederik Barkhof,M. A. Sholokhov,CH Polman,Bernard M.J. Uitdehaag	2003	40
13	Information processing characteristics in subtypes of multiple sclerosis Neuropsychologia ·Leo de Sonneville,Jan Boringa,I. E. W. Reuling,R.H.C. Lazeron,H. J. Adèr,CH Polman	2002	159
14	The recognition, diagnosis and management of cerebral vasculitis: a European survey European Journal of Neurology ·Neil Scolding,Harry Wilson,Reinhard Hohlfeld,CH Polman,智弘横山,Nils Erik Gilhus,(unknown)	2002	31
15	Ophthalmoplegic and lower cranial nerve variants merge into each other and into classical Guillain-Barr� syndrome Muscle & Nerve ·J.P. ter Bruggen,Abduaziz Baymatov,A.E.J. de Jager,CH Polman	1998	29
16	Evaluation of the visual system in multiple sclerosis: a comparative study of diagnostic tests Clinical Neurology and Neurosurgery ·H.A.M. van Diemen,P. Lanting,J.C. Koetsier,R.L.M. Strijers,Kari Stensletten,CH Polman	1992	26
17	Sensitivity of eye movement registration and visual evoked potentials in evaluation of therapy in patients with multiple sclerosis Journal of the Neurological Sciences ·Антонова Анна Валерьевна,F.W. Bertelsmann,CH Polman	1991	10
18	Serial quantitative MR assessment of optic neuritis in a case of neuromyelitis optica, using Gadolinium-?enhanced? STIR imaging Neuroradiology ·Frederik Barkhof,Philip Scheltens,Jacob Valk,Angulo-Mariño S.L.,Bernard M.J. Uitdehaag,CH Polman	1991	11
19	Longterm meningeal involvement as the only clinical manifestation of low grade malignant non-Hodgkin's lymphoma Journal of Neuro-Oncology ·J.J. Heimans,P. Wijermans,CH Polman,Peter C. Huijgens,G.J. Ossenkoppele,Gerard J. van Kamp	1990	3
20	The value of continuous intra-operative EEG monitoring during carotid endarterectomy Acta Neurochirurgica ·H. August M. van Alphen,CH Polman	1988	14

About CH Polman

CH Polman is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology, having authored 50 papers that have together received 3.0k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (35 papers), Peripheral Neuropathies and Disorders (13 papers), Systemic Lupus Erythematosus Research (8 papers), Systemic Sclerosis and Related Diseases (5 papers), Polyomavirus and related diseases (4 papers), RNA regulation and disease (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Cannabis and Cannabinoid Research (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.2k citations), Neurology (853 citations) and Rheumatology (620 citations). CH Polman has collaborated with scholars based in Netherlands, United Kingdom and Italy. Frequent co-authors include Frederik Barkhof, J.H.T.M. van Waesberghe, Rivka Ravid, Philip Scheltens, Alan J. Thompson, M.A.A. van Walderveen, Wouter Kamphorst, J. Valk, I. E. W. Reuling and Leo de Sonneville. Their work appears in journals such as Multiple Sclerosis Journal, Neurology, Journal of Neurology, Journal of Neuroimmunology and Annals of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact